[Translation] Bioequivalence trial of tiopride hydrochloride tablets in Chinese healthy subjects in a single-center, randomized, open-label, two-period, two-crossover design
评价天津中新药业集团股份有限公司新新制药厂的盐酸硫必利片(规格:100mg/片(按硫必利计))与持证商为Sanofi S.p.A.的盐酸硫必利片(规格:100mg/片(按硫必利计),商品名:SEREPRILE,赛诺菲生产)在健康成年受试者餐后状态下单次口服给药的人体生物等效性。
[Translation] Evaluation of tiapride hydrochloride tablets (specification: 100mg/tablet (calculated by tiapride)) from Xinxin Pharmaceutical Factory of Tianjin Zhongxin Pharmaceutical Group Co., Ltd. and tiapride hydrochloride tablets (specification: Sanofi S.p.A.) 100mg/tablet (calculated as tiapride, trade name: SEREPRILE, manufactured by Sanofi) is the human bioequivalence of a single oral administration in healthy adult subjects in the postprandial state.